Subsequently, a coIP experiment using an anti-syntenin-1 antibody demonstrated the binding of endogenous syntenin-1 and TBK1 in A549 NSCLC cells (Fig. 1E). Here, SDCBP is linked to non-small cell lung carcinoma.